GPT Analysis

Empower Your Investments! Unleash the Potential with Smart Stock Analysis!

United States Hong Kong China Singapore Japan India
Sorting Arrows
Symbol
▲ ▼
Company Name Rating
▲ ▼
Recommendation
▲ ▼
Evaluation from GPT Action Time
▲ ▼
AARVI Aarvi Encon Limited None None None

None
AARVI Aarvi Encon Limited None None None

None
AARVI Aarvi Encon Limited None None None

None
AARVI Aarvi Encon Limited None None None

None
AARVEEDEN Aarvee Denims & Exports Limited None None None

None
AARVEEDEN Aarvee Denims & Exports Limited None None None

None
AARVEEDEN Aarvee Denims & Exports Limited None None None

None
AARVEEDEN Aarvee Denims & Exports Limited None None None

None
AARTISURF Aarti Surfactants Limited 60 Positive Aarti Surfactants Limited operates in the specialty chemicals sector, specifically in the production of surfactants and chemical compounds. The company has shown a positive revenue growth of 4.3% and earnings growth of 94.2%. However, its profit margins are relatively low compared to industry peers at 2.1%. AARTISURF.NS has a moderate trailing P/E ratio of 37.3, indicating a potential overvaluation of the stock. The company's return on equity (ROE) of 8.4% and return on assets (ROA) of 5% suggests an average performance. A high debt-to-equity ratio of 88.8% indicates significant reliance on debt for financing operations. AARTISURF.NS has a market cap of INR 5,188,207,104, making it a relatively small-cap stock. Overall, considering its financial indicators, moderate valuation, and industry performance, it is recommended to approach this investment with caution.

2023-07-24 05:04:00
AARTISURF Aarti Surfactants Limited None None None

None
AARTISURF Aarti Surfactants Limited None None None

None
AARTISURF Aarti Surfactants Limited None None None

None
AARTIPHARM Aarti Pharmalabs Limited 75 Positive Aarti Pharmalabs Limited (AARTIPHARM.NS) is a well-established pharmaceutical company operating in the Indian market. The stock has shown positive growth over the past year, with a year change of 30.53%. The day high and day low indicate a relatively stable trading range. However, the stock's current market price is slightly below the year high of 566.95 INR, suggesting a potential upside. The stock's 50-day average of 479.85 INR is higher than the last price of 511.90 INR, indicating an upward trend. With a market capitalization of 46,391,448,846.86 INR and a high trading volume, the stock is considered liquid. Considering these factors, the sentiment for AARTIPHARM.NS is positive and the rating is 75 out of 100.

2024-05-03 13:32:43
AARTIIND Aarti Industries Limited None None None

None
AARTIIND Aarti Industries Limited None None None

None
AARTIIND Aarti Industries Limited None None None

None
AARTIIND Aarti Industries Limited None None None

None
AARTIDRUGS Aarti Drugs Limited 65 Positive Aarti Drugs Limited (AARTIDRUGS.NS) is a pharmaceutical company listed on the National Stock Exchange of India. Based on the current financial indicators, the stock appears to be performing reasonably well. The day high and low indicate a moderate level of volatility in trading. The market cap is significant, indicating the company's size and stability. YearChange of 10.44% suggests a positive growth trend. The stock is currently priced close to the 200-day average, indicating it might be fairly valued. However, the stock has experienced a decline in price compared to the year high of 645.75. The relatively low average volume over the past ten days suggests moderate investor interest. Overall, the stock presents a mixed picture of performance and market sentiment.

2024-05-03 13:21:15
AARTECH Aartech Solonics Limited None None None

None
AARTECH Aartech Solonics Limited None None None

None